Marimekko Corporation: Managers' transactions (Chen)
Marimekko Corporation, Managers’ transactions, 22 May 2023 at 1.00 p.m.
Marimekko Corporation: Managers' transactions (Chen)
Marimekko Corporation’s Annual General Meeting held on 13 April 2023 resolved that approximately 40 percent of the annual remuneration of the members of the Board of Directors will be paid in Marimekko’s shares acquired from the market. Pursuant to the resolution, shares have been acquired as follows:
____________________________________________
Person subject to the notification requirement
Name: Chen, Carol
Position: Member of the Board/Deputy member
Issuer: Marimekko Corporation
LEI: 74370053IOY42B9YJ350
Notification type: INITIAL NOTIFICATION
Reference number: 74370053IOY42B9YJ350_20230519150338_29
____________________________________________
Transaction date: 2023-05-19
Venue: XHEL
Instrument type: SHARE
ISIN: FI0009007660
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 1118 Unit price: 0.00 EUR
Aggregated transactions
(1): Volume: 1118 Volume weighted average price: 0.00 EUR
MARIMEKKO CORPORATION
Released by: Corporate Communications, Anna Tuominen, tel. +358 40 584 6944
DISTRIBUTION:
Nasdaq Helsinki Ltd
Key media
Marimekko is a Finnish lifestyle design company renowned for its original prints and colors. The company’s product portfolio includes high-quality clothing, bags and accessories as well as home décor items ranging from textiles to tableware. When Marimekko was founded in 1951, its unparalleled printed fabrics gave it a strong and unique identity. In 2022, the company's net sales were EUR 167 million and comparable operating profit totaled EUR 30.4 million. Globally, there are roughly 150 Marimekko stores, and online store serves customers in 35 countries. The key markets are Northern Europe, the Asia-Pacific region and North America. The Group employs about 460 people. The company’s share is quoted on Nasdaq Helsinki Ltd. www.marimekko.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Schweiter strengthens its Core Materials business – acquisition of JMB Wind Engineering completed1.6.2023 06:00:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Schweiter strengthens its Core Materials business – acquisition of JMB Wind Engineering completed Schweiter Technologies is increasing its 40% minority holding by taking over the remaining 60% of the stock. The agreement to purchase the rest of the shares in JMB Wind Engineering (“JMB”) has been signed and completed, further strengthening the Core Materials business of 3A Composites. Steinhausen, 1 June 2023 – JMB (www.jmbwind.com) is a leading developer and producer of core material kits – primarily balsa and PET products for wind turbines. It is headquartered in Goleniów, Poland and has subsidiaries in Poland, Portugal and Brazil. The company acquired has approximately 430 employees and achieved sales of around EUR 70 million in the 2022 business year. Schweiter Technologies acquired a 40% share of JMB in 2021 to establish a strategic partnership with a leading European kitting company. The acquisition of the remaining holding in JMB and the
SET Launches New Trading System Leveraging Nasdaq Technology to Meet End-to-End Investment Needs1.6.2023 04:00:00 CEST | Press release
BANGKOK, Thailand and NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- The Stock Exchange of Thailand (SET) has successfully launched its new trading system, together with market data distribution and market surveillance systems, based on Nasdaq (Nasdaq: NDAQ) technology. All systems are running seamlessly and operating at full efficiency in line with international standards and best practice. This newly developed state-of-the-art solution will support increasing transaction volumes and a variety of innovative investment products, whilst further enhancing the trust and integrity of the market. This implementation marks a significant milestone in the ongoing development of the modern Thai capital market, established to promote economic growth and stability, and to develop people’s standard of living. Today, SET has the highest liquidity among ASEAN exchanges, a position the exchange has held for more than 10 years. In 2022, capital raised through IPOs totaled 3.46 billion USD, the highest in
Havila Kystruten AS: Sustainability Report 2022 and Human Rights and Transparency Act 20221.6.2023 00:00:32 CEST | Press release
Please find attaced the - Sustainability Report 2022 - Human Rights and Transparency Act 2022 Attachments HKY - Sustainability Report 2022HKY Human Rights and Transparency Act 2022
Santhera Publishes Annual Report 202231.5.2023 23:50:39 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, May31, 2023 – Santhera Pharmaceuticals (SIX: SANN) announces the publication of its Annual Report 2022 with fully audited results for the year ended December 31, 2022. Santhera’s Annual Report 2022 provides comprehensive and detailed information on the Company, its strategy, business, financial performance, governance and compensation in 2022, and confirms the preliminary unaudited 2022 annual results which were published on April 27, 2023. The Annual Report 2022 is available for download on the Company’s website at www.santhera.com/financial-reports. Corporate calendar June 27, 2023 Annual General Meeting About Santhera Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular and pulmonary diseases with high unmet medical need. The Company has an exclusive license for all indications worldwide to vamor
Havila Kystruten AS: Årsrapport 2022 med Revisors rapport31.5.2023 23:30:41 CEST | Pressemelding
Vedlagt følger selskapets årsrapport og revisors rapport for 2022. Ordinær generalforsamling holdes 16. juni 2023. Innkalling og agenda sendes 2. juni 2023. Kontakter: Administrerende direktør Bent Martini, +47 905 99 650 Finansdirektør Arne Johan Dale, +47 909 87 706 Vedlegg HKY_2022_Annual Report